RIPK3 and metabolic dysfunction-associated steatotic liver disease: Notably, macrophages expressed far more RIPK3 than hepatocytes or HSCs (Figure 4G), indicating that they are likely the primary contributors to RIPK3 upregulation observed in MASLD livers.